MSF Science Portal
My saved items
Conference Material > Slide Presentation
Preliminary data on safety and effectiveness of six-month all-oral regimens in patients with rifampicin-resistant tuberculosis in Belarus
Yatskevich N,
Hurevich H,
Solodovnikova V,
Garsevanidze E,
Lachenal N,
Alvarez JL,
Sitali N,
Sinha A,
Skrahina A
Download
View
Share
Linked Items
Share
Download
No Abstract Available
Countries
Belarus
Subject Area
antibiotic resistance
tuberculosis
antimicrobial resistance
DOI
10.57740/3sk2-bf43
Published Date
07-Jun-2023
Languages
English
Conference
MSF Scientific Day International 2023
Linked Items
Preliminary data on safety and effectiveness of six-month all-oral regimens in patients with rifampicin-resistant tuberculosis in Belarus
07-Jun-2023
Preliminary data on safety and effectiveness of six-month all-oral regimens in patients with rifampicin-resistant tuberculosis in Belarus
07-Jun-2023
